Merck & Co's key cancer drug Keytruda has been approved for use in Europe in combination with chemotherapy in previously untreated lung cancer patients, marking a further advance for the product after uncertainty about its EU prospects a year ago. ...
Original Article: Merck's Keytruda clocks up new win as EU approves chemo cocktail